Signal Pharmaceuticals, Roche Bioscience deal

The companies entered a three-year agreement to use Signal's neuronal cell line technology to develop therapeutics for pain and lower urinary tract disorders. Signal will use the technology to develop peripheral neuronal cell lines for use in drug discovery and to identify new targets for therapeutic intervention. ...